跳至主要内容
临床试验/NCT00110552
NCT00110552已完成1 期

Effects of a Cognitive Enhancer on Memory and Cognitive Performance

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2005年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
111
试验地点
1
主要终点
Cognitive function

研究概览

简要总结

The purpose of this study is to determine the effectiveness of the herb sage in improving the mental function of individuals with Alzheimer's disease.

Study hypothesis: The administration of sage will improve cognitive function in patients with mild Alzheimer's disease.

详细描述

The herb sage has been shown to enhance memory and mental function in healthy, young adults. However, studies assessing the herb's effectiveness in older adults with symptoms of Alzheimer's disease are limited. This study will determine the effect of sage extract on the cognitive function of patients with mild Alzheimer's disease.

This study will last 6 weeks and will comprise 4 study visits, approximately 10 days apart. Participants will be randomly assigned to receive either sage pills or no treatment during each 10-day period. The treatment assignments will be switched in 10-day intervals, so that during the course of the study, each participant will undergo two periods of sage treatment and two periods without treatment. At each study visit, participants will undergo cognitive testing, including tests to determine attention, memory, and visual cognition. Participants will also undergo an electroencephalogram (EEG) and an electrocardiogram (ECG) at each visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
50 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of mild Alzheimer's disease
  • Partner, friend, child, spouse, or relative willing to accompany participants to all study visits, provide informed consent, monitor participants' pill-taking, and communicate changes in participants' health during the study

排除标准

  • Significant medical illness other than Alzheimer's disease

研究组 & 干预措施

1

Experimental

Sage capsules taken by mouth

干预措施: Salvia officinalis (sage) (Drug)

结局指标

主要结局

Cognitive function

时间窗: 8 weeks

次要结局

  • cognitive electrophysiology(8 weeks)
  • Stress(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barry S. Oken

MD

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验